科学文献

Ciltacabtagene Autoleucel Versus Idecabtagene Vicleucel in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma with 2-4 Prior Lines of Therapy: Updated Matching-Adjusted Indirect Comparison

Nieves Lopez-Muñoz, Noffar Bar, Joris Diels, Suzy van Sanden , João Mendes, Seina Lee, Teresa Hernando, Nikoletta Lendvai, Nitin Patel, Tadao Ishida, Jeremy Er, Simon J Harrison

Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial

Nieves Lopez-Muñoz, Noffar Bar, Joris Diels, Suzy van Sanden , João Mendes, Seina Lee, Teresa Hernando, Nikoletta Lendvai, Nitin Patel, Tadao Ishida, Jeremy Er, Simon J HarrisonHermann Einsele , Jesús San-Miguel , Binod Dhakal , Cyrille Touzeau , Xavier Leleu , Niels Wcj van de Donk , Surbhi Sidana , Albert Oriol , Yael C Cohen , Simon J Harrison , María-Victoria Mateos , Joaquín Martínez-López , Paolo Corradini , Lionel Karlin , Diana Chen , Quanlin Li , Tzu-Min Yeh , Katherine Li , Vicki Plaks , Ana Slaughter , Carolina Lonardi , Nina Benachour , Arnab Ghosh , Martin Vogel , Jordan M Schecter , Nikoletta Lendvai , Mythili Koneru , Nitin Patel , Erika Florendo , Phoebe Joy Ho , Rakesh Popat

Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4

Paula Rodríguez-Otero , Surbhi Sidana , Mathilde Kouwenhoven , Jordan M Schecter , Nikoletta Lendvai , Kevin C De Braganca , Ana Slaughter , Carolina Lonardi , Philip Vlummens , Helen Varsos , Christina Corsale , Deepu Madduri , Hao Zhao , Katherine Li , Erin Lee , Loreta Marquez , Man Zhao , Tzu-Min Yeh , Diana Chen , Vicki Plaks , Rocio Montes de Oca , Erika Florendo , Nitin Patel , Muhammad Akram , Mythili Koneru , Bianca D Santomasso , Jaime Gállego Perez-Larraya , Niels Wcj van de Donk

Survival Outcomes with Cilta-cel Versus Conventional Treatment Regimens for Patients with Lenalidomide-Refractory Multiple Myeloma Using Inverse Probability of Treatment Weighting

Rafael Fonseca , Joris Diels , Francesca Ghilotti , João Mendes , Sandra Van Hoorenbeeck , Seina Lee , Jordan M Schecter , Nikoletta Lendvai , Nitin Patel , Ana Triguero , Winfried Alsdorf , Niels W C J van de Donk , Margherita Ursi

Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma

Sundar Jagannath, Thomas G Martin, Yi Lin, Adam D Cohen, Noopur Raje, Myo Htut, Abhinav Deol, Mounzer Agha, Jesus G Berdeja, Alexander M Lesokhin, Jessica J Liegel, Adriana Rossi, Alex Lieberman-Cribbin, Saad Z Usmani, Binod Dhakal, Samir Parekh, Hui Li, Feng Wang, Rocio Montes de Oca, Vicki Plaks, Huabin Sun, Arnob Banerjee, Jordan M Schecter, Nikoletta Lendvai, Deepu Madduri, Tamar Lengil, Jieqing Zhu, Mythili Koneru, Muhammad Akram, Nitin Patel, Octavio Costa Filho, Andrzej J Jakubowiak, Peter M Voorhees

我们与学术机构开展合作研究，以评估我们的管线产品。以下是发表的相关文献。

Ciltacabtagene Autoleucel Versus Idecabtagene Vicleucel in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma with 2-4 Prior Lines of Therapy: Updated Matching-Adjusted Indirect Comparison

Cilta-cel in lenalidomide-refractory multiple myeloma (CARTITUDE-4): an updated analysis including overall survival from an open-label, multicentre, randomised, phase 3 trial

Clinical experience with cranial nerve palsy in patients infused with ciltacabtagene autoleucel for the treatment of relapsed/refractory MM in CARTITUDE-1, -2, and -4

Survival Outcomes with Cilta-cel Versus Conventional Treatment Regimens for Patients with Lenalidomide-Refractory Multiple Myeloma Using Inverse Probability of Treatment Weighting

Long-Term (≥5-Year) Remission and Survival After Treatment With Ciltacabtagene Autoleucel in CARTITUDE-1 Patients With Relapsed/Refractory Multiple Myeloma

您即将离开我们的网站